News related to the Enterprise, its Stakeholders, and HIV Vaccine Research

Call For Applications: AIDS Vaccine 2012 Local Host - December 15, 2009

The Global HIV Vaccine Enterprise, the organizer of the annual AIDS Vaccine conference, is accepting applications for Local Host of AIDS Vaccine 2012 to be held in North America. The annual AIDS Vaccine conference is the largest and most important global scientific conference focused on AIDS vaccine research. Interested applicants should review and complete the attached application form and submit to Amapola Manrique ( by March 15, 2010.

Uganda Institute to Host the African AIDS Vaccine Programme (AAVP) - December 14, 2009

The Uganda Virus Research Institute (UVRI) based in Entebbe, Uganda was recommended to host the Secretariat of the African AIDS Vaccine Programme (AAVP), an initiative to support a coordinated international effort to promote the development of and future access to HIV vaccines suitable for use in Africa. The AAVP Secretariat has been based in Geneva, Switzerland since 2000. A transition of AAVP to a fully functional African programme began more than a year ago and should be complete by the first quarter of 2010.

IAVI Statement in Response to MDP 301 Phase III Trial of a Vaginal Microbicide - December 14, 2009

The International AIDS Vaccine Initiative released a statement congratulating the partners involved in the MDP 301 Phase III clinical trial of a vaginal microbicide on the successful conduct of the largest microbicide trial completed to date. IAVI said the trial itself provided other achievements that will help advance microbicide development and HIV prevention research generally. Please see the below attachment for the full statement.

Major Study Finds Anti-HIV Gel Ineffective Among Women (NIAID Statement) - December 14, 2009

According to a NIAID statement, an investigational vaginal gel that had demonstrated in earlier testing some potential for inhibiting male-to-female sexual transmission of HIV was ineffective when tested in a larger clinical trial. Please see the below attachment for the full statement.

AVAC Says MDP 301 Microbicide Trial Results Disappointing, But Researchers and 9,400 Trial Volunteers Deserve Praise for Successful Trial - December 14, 2009

The Microbicides Development Programme announced that its MDP 301 effectiveness trial, which was conducted among almost 9,400 women in four African countries, found no evidence that the PRO 2000 microbicide reduces the risk of HIV infection.

Mahidol University Faculty of Tropical Medicine and the Thailand Ministry of Public Health to Host AIDS Vaccine 2011 - December 9, 2009

The Global HIV Vaccine Enterprise announced that the Faculty of Tropical Medicine, Mahidol University and the Department of Disease Control, Ministry of Public Health, Thailand, will serve as Local Hosts for AIDS Vaccine 2011, the largest and most important global scientific conference focused on AIDS vaccine research. AIDS Vaccine 2011will be held 12-15 September 2011 in Bangkok, Thailand.  The full announcement is below.

PBS Releases Special World AIDS Day Episode Featuring Segment on Vaccine Trials - December 7, 2009

IN THE LIFE, a public television documentary series, released a special World AIDS Day episode entitled "Creating Solutions." This episode includes a special segment on the search for an AIDS vaccine. It features interviews with Anthony Fauci and Gary Nabel from the NIH; Sarah Schlesinger from Rockefeller University and Mitchell Warren of AVAC. If you live in the US, visit the following link to find out when the episode will air on your local station:

Request for Concept Proposals - Creative and Novel Ideas in HIV Research Program for Early Career Investigators - December 2, 2009

The International AIDS Society in collaboration with the Centers for AIDS Research Program, U.S. National Institutes of Health, request concept proposals for a research grant program for early career investigators with no prior experience in HIV research. Please click the below link to learn more about the Creative and Novel Ideas in Research Awards Program.

IAVI Calls for Strong and Sustained Global Investment in New HIV Prevention Tools - December 1, 2009

To read the IAVI statement on World AIDS Day, please click the below link.

Europe Can and Should Do More - Alan Bernstein and Jeannette Kagame Guest Column - November 30, 2009

Alan Bernstein, executive director of the Global HIV Vaccine Enterprise and Jeannette Kagame, First Lady of the Republic of Rwanda and high representative of African AIDS Vaccine Programme, wrote a Guest Column for the special World AIDS Day edition of the Financial Times, which focused on the need for greater global collaboration, investments and more effective partnerships between the North and South. The full column is available below.

Syndicate content
Global HIV Vaccine Enterprise, 64 Beaver Street, # 352, New York, NY 10004 | +1 212-461-3692 or toll free at +1-866-966-4483
All Content ©2005 - 2013 Global HIV Vaccine Enterprise   |   Terms of Use   |   Privacy Policy   |   Log In / My Account